Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. (Q50335804)

5 March 2018

title

Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. (English)

1 reference

5 March 2018

0 references

Hélène Sebban-Benin

1

1 reference

5 March 2018

Alessandra Pescatore

2

1 reference

5 March 2018

Francesca Fusco

3

1 reference

5 March 2018

Valérie Pascuale

4

1 reference

5 March 2018

Jérémie Gautheron

5

1 reference

5 March 2018

Shoji Yamaoka

6

1 reference

5 March 2018

Anne Moncla

7

1 reference

5 March 2018

Matilde Valeria Ursini

8

1 reference

5 March 2018

Gilles Courtois

9

1 reference

5 March 2018

publication date

29 August 2007

1 reference

5 March 2018

published in

Human Molecular Genetics

1 reference

5 March 2018

volume

16

1 reference

5 March 2018

issue

23

1 reference

5 March 2018

page(s)

2805-2815

1 reference

5 March 2018

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

IkappaB kinase complexes: gateways to NF-kappaB activation and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Two pathways to NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

NF-kappaB-related genetic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

NEMO/IKK gamma-deficient mice model incontinentia pigmenti.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM237

21 January 2018

Identifiers

DOI

10.1093/HMG/DDM237

1 reference

5 March 2018

release_uiyw7sy2cjgpznnkrgsqjx37vq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uiyw7sy2cjgpznnkrgsqjx37vq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

5 March 2018